Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 119834
Published online Aug 15, 2026. doi: 10.4251/wjgo.119834
Published online Aug 15, 2026. doi: 10.4251/wjgo.119834
Figure 3 MCM10 overexpression promotes hepatocellular carcinoma tumorigenesis in vitro and in vivo.
A and B: The mRNA and protein levels of MCM10-overexpressed hepatocellular carcinoma cells and corresponding control cells; C: Cell viability was detected by Cell Counting Kit-8 assay in MCM10-overexpressed cells (Hep3B and HCCLM3); D: Representative images and summary of foci formation in MCM10-overexpressed cells (Hep3B and HCCLM3); E: Cell proliferation was detected by EdU assay in MCM10-overexpressed cells (Hep3B and HCCLM3); F: Representative images and summary of soft agar colony formation in MCM10-overexpressing cells (Hep3B and HCCLM3); G: Subcutaneous tumors formed in nude mice of HCCLM3-MCM10 and control cells (n = 5); H: Tumor growth curves were summarized in the line chart between MCM10-overexpressing cells and control cells; I: The tumor weight of xenografts in nude mice. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Chen YR, Wang G, He LJ, Ye HW, Wang LF, Zou DD, Wang MQ, Xie HW, Zhu SL, Wang XY. MCM10 promotes hepatocellular carcinoma progression through cyclin D1 regulation. World J Gastrointest Oncol 2026; 18(8): 119834
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/119834.htm
- DOI: https://dx.doi.org/10.4251/wjgo.119834